Clinical trial
Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who…
NCT00253487 · Children's Hospital Medical Center, Cincinnati, Other · Completed
Key facts
| NCT number | NCT00253487 |
|---|---|
| Title | Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas |
| Official title | A Pilot Study of Temozolomide and O-Benzylguanine for Treatment of High-Grade Glioma, Using Autologous Peripheral Blood Stem Cells Genetically Modified for Chemoprotection |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | O6-benzylguanine, busulfan, temozolomide, adjuvant therapy, autologous bone marrow transplantation, conventional surgery, peripheral blood stem cell transplantation, radiation therapy |
| Start date | Aug 1, 2005 |
| Primary completion | Aug 1, 2012 |
| Completion | Aug 1, 2012 |
| First posted | Nov 15, 2005 |
| Last update posted | Jan 6, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: